三级医院住院患者抗菌药物治疗前病原学送检率管理现状调查
作者:
作者单位:

1.南京医科大学第一附属医院感染管理处, 江苏 南京 210029;2.江苏大学附属武进医院感染管理科, 江苏 常州 213009;3.徐州医科大学武进临床学院感染管理科, 江苏 常州 213009

作者简介:

通讯作者:

李占结   E-mail: 511502052@qq.com

中图分类号:

R197.323.4

基金项目:

国家重点研发计划-2020YFC0848100;南京医科大学第一附属医院青年基金培育计划(PY2022017);江苏省人民医院第三期优秀中青年人才支持计划(YNRCQN0314)


Current management status of pathogen examination rate before antimicrobial treatment for hospitalized patients in tertiary hospitals
Author:
Affiliation:

1.Infection Management Department, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China;2.Infection Management Department, Wujin Hospital Affiliated with Jiangsu University, Changzhou 213009, China;3.Infection Management Department, The Wujin Clinical College of Xuzhou Medical University, Changzhou 213009, China

Fund Project:

  • 摘要
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 文章评论
    摘要:

    目的 调查三级医院住院患者抗菌药物治疗前病原学送检率管理现状, 为进一步提高送检率提供依据。 方法 通过"问卷星"平台设计调查问卷, 选取江苏省38所三级综合医院, 调查内容包括住院患者抗菌药物治疗前病原学送检率及管理情况、重点抗菌药物联用前病原学送检率、医院感染诊断相关病原学送检率等。 结果 38所三级医院中, 78.95%(30所)的医院由医院感染管理科负责送检率监测; 100%的医院执行标准等于或高于全部类(30%)、限制类(50%)、特殊类(80%)的标准; 病原学送检纳入降钙素原(PCT)、1, 3-β-D葡聚糖试验(G试验)、半乳甘露聚糖(GM)试验、白介素(IL)-6的医院均在50%以上, 其中纳入PCT的医院达到73.68%;用药目的中15.79%(6所)医院不只抓取治疗用药; 用药途径中31.58%(12所)的医院纳入局部用药; 抗菌药物使用抓取时间方面, 52.63%的医院(20所)抓取医嘱开具时间; 病原学送检抓取时间方面, 31.58%(12所)的医院抓取医嘱开具时间。抗菌药物治疗前病原学送检率平均数据达到相关要求, 重点抗菌药物联用前病原学送检率和医院感染诊断相关病原学送检率平均数据未达到相关要求, 各医院之间差距较大。 结论 抗菌药物治疗前病原学送检率管理上, 各医院在较多方面执行不统一。各医疗机构应严格按照规范要求, 进一步推进抗菌药物治疗前病原学送检率的同质化监测。

    Abstract:

    Objective To investigate the current management status of pathogen examination rate before antimicrobial treatment for hospitalized patients in tertiary hospitals, and provide reference to further improve the examination rate. Methods Questionnaire was designed using the "Questionnaire Star" platform. 38 tertiary comprehensive hospitals in Jiangsu Province were selected. The survey included the pathogen examination rate before antimicrobial treatment and management status of hospitalized patients, the pathogen examination rate before treatment with key antimicrobial combination, and the pathogen examination rate related to healthcare-associated infection(HAI) diagnosis. Results Among the 38 tertiary hospitals, 78.95% (n=30) monitored pathogen examination rate by the department of HAI management, 100% implemented standards equal to or higher than the standards for all categories (30%), restricted categories (50%), and special categories (80%) of antimicrobial agents, respectively. More than 50% hospitals included the detection of procalcitonin (PCT), 1, 3-β-D-glucan test (G-test), galactomannan test (GM test), and interleukin-6 (IL-6) in the pathogen examination, with PCT included in 73.68% hospitals. 15.79% (n=6) hospitals did not only capture therapeutic antimicrobial use in terms of medication purpose; 31.58% (n=12) hospitals included local antimicrobial use in terms of medication route; 52.63% (n=20) hospitals captured the time of medical prescription for the use of antimicrobial agents; 31.58% (n=12) hospitals captured the time of medical prescription for the pathogen examination. The average data of pathogen examination rate before antimicrobial treatment met the relevant requirements, while the average data of pathogen examination rate before treatment with key antimicrobial combination and that relevant to HAI diagnosis did not. Differences among hospitals were significant. Conclusion The management of pathogen examination rate before antimicrobial treatment in various hospitals implemented inconsistently in multiple aspects. Each medical institution should further promote the homogeneous monitoring on pathogen examination rate before antimicrobial treatment in strict accordance with the stan-dardized requirements.

    参考文献
    相似文献
引用本文

陈晓旭,李松琴,刘娟,等.三级医院住院患者抗菌药物治疗前病原学送检率管理现状调查[J]. 中国感染控制杂志,2023,(5):532-538. DOI:10.12138/j. issn.1671-9638.20233700.
Xiao-xu CHEN, Song-qin LI, Juan LIU, et al. Current management status of pathogen examination rate before antimicrobial treatment for hospitalized patients in tertiary hospitals[J]. Chin J Infect Control, 2023,(5):532-538. DOI:10.12138/j. issn.1671-9638.20233700.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2022-12-19
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-04-28
  • 出版日期: